260 related articles for article (PubMed ID: 6311492)
1. Susceptibility of 324 nonfermentative gram-negative rods to 6 cephalosporins and azthreonam.
Appelbaum PC; Tamim J; Pankuch GA; Aber RC
Chemotherapy; 1983; 29(5):337-44. PubMed ID: 6311492
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of ceftazidime and ceftriaxone.
Keenholtz SL; Jacobus NV; Tally FP; Gorbach SL
Clin Ther; 1983; 5(6):603-16. PubMed ID: 6313195
[TBL] [Abstract][Full Text] [Related]
3. [Comparative in vitro activity of 5 beta-lactams (cefoperazone, cefsulodin, ceftazidime, azthreonam, N-formimidoyl-thienamycin) on 90 strains of Pseudomonas aeruginosa with various levels of resistance to ticarcillin].
Le Noc P; Robert J; Le Noc D
Pathol Biol (Paris); 1984 May; 32(5):404-7. PubMed ID: 6429611
[TBL] [Abstract][Full Text] [Related]
4. The activity of ceftazidime compared with those of aztreonam, newer cephalosporins and Sch 29482 against nonfermentative gram-negative bacilli.
Schell RF; Francisco M; Bihl JA; LeFrock JL
Chemotherapy; 1985; 31(3):181-90. PubMed ID: 3888543
[TBL] [Abstract][Full Text] [Related]
5. Comparative in vitro activity of first, second and third generation cephalosporins.
Forsgren A
Acta Pathol Microbiol Scand B; 1981 Aug; 89(4):221-5. PubMed ID: 6274143
[TBL] [Abstract][Full Text] [Related]
6. Azthreonam activity against gram-negative bacilli.
Bremner DA
Chemotherapy; 1984; 30(1):44-8. PubMed ID: 6537908
[TBL] [Abstract][Full Text] [Related]
7. [In-vitro activity of ceftriaxone on Gram-negative bacilli with various resistance phenotypes to cephalosporins. Comparison with cefotaxime, cefmenoxime, moxalactam, ceftazidime].
Rouhan D; Le Noc P; Le Noc D
Pathol Biol (Paris); 1986 May; 34(5):404-9. PubMed ID: 3534713
[TBL] [Abstract][Full Text] [Related]
8. Comparison of in vitro activities of eight beta-lactamase-stable cephalosporins against beta-lactamase-producing gram-negative bacilli.
Verbist L
Antimicrob Agents Chemother; 1981 Mar; 19(3):407-13. PubMed ID: 6972728
[TBL] [Abstract][Full Text] [Related]
9. [In vitro activity of cefmenoxime (SCE 1365) against 616 hospital strains of gram-negative bacilli chosen for beta-lactam resistance. Comparison with cefotaxime, lamoxactam and ceftazidime].
Le Noc P; Bryskier A; Le Noc D
Pathol Biol (Paris); 1983 May; 31(5):351-6. PubMed ID: 6312396
[TBL] [Abstract][Full Text] [Related]
10. [Comparative activity of dibekacin and several cephalosporins on Pseudomonas aeruginosa].
Carlone NA; Cuffini AM; Forno-Pizzoglio M; Aragno M
G Batteriol Virol Immunol; 1983; 76(7-12):246-56. PubMed ID: 6099297
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the beta-lactamase stability and the in-vitro activity of cefoperazone, cefotaxime, cefsulodin, ceftazidime, moxalactam and ceftriaxone against Pseudomonas aeruginosa.
Livermore DM; Williams RJ; Williams JD
J Antimicrob Chemother; 1981 Oct; 8(4):323-31. PubMed ID: 6271726
[No Abstract] [Full Text] [Related]
12. Antibacterial activity in vitro and regression studies for ceftazidime and ceftriaxone.
Frimodt-Møller N; Højbjerg T; Hvass E; Møller S; Mortensen I; Thomsen VF
Acta Pathol Microbiol Immunol Scand B; 1985 Jun; 93(3):181-8. PubMed ID: 3929558
[TBL] [Abstract][Full Text] [Related]
13. The effect of N-formimidoyl thienamycin, ceftazidime, cefotiam, ceftriaxone and cefotaxime on non-fermentative Gram-negative rods, Aeromonas, Plesiomonas and Enterobacter agglomerans.
von Graevenitz A; Bucher C
Infection; 1982; 10(5):293-8. PubMed ID: 6293976
[TBL] [Abstract][Full Text] [Related]
14. An in-vitro comparison of new cephalosporins with special reference to Pseudomonas aeruginosa.
van Klingeren B
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():97-105. PubMed ID: 19810171
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of antibacterial activities of cephalosporins].
Kayser FH; Kohler ML
Schweiz Med Wochenschr; 1984 Feb; 114(5):156-61. PubMed ID: 6701496
[TBL] [Abstract][Full Text] [Related]
16. In-vitro activity of ceftazidime compared with other beta-lactam antibiotics.
Clarke AM; Zemcov SJ
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():57-62. PubMed ID: 19810169
[TBL] [Abstract][Full Text] [Related]
17. [The effect of cefepime on ceftazidime, cefotaxime and imipenem resistant strains of Acinetobacter, Xanthomonas, Pseudomonas, Flavobacterium, Sphingobacterium and on producers of extended spectrum beta-lactamases (ESBL) with resistance transfer].
Blahová J; Hupková-Lesická M; Králiková K; Krcméry V; Kubonová K
Cas Lek Cesk; 1997 Mar; 136(5):154-6. PubMed ID: 9221190
[TBL] [Abstract][Full Text] [Related]
18. [Comparative in vitro activity of 2 monobactams (RO 172301 (AMA 1080)and aztreonam), ceftazidime and cefotaxime on Gram-negative bacilli].
Thabaut A; Meyran M; Huerre M
Pathol Biol (Paris); 1985 May; 33(5):404-7. PubMed ID: 3929217
[TBL] [Abstract][Full Text] [Related]
19. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Jones RN; Sader HS; Fritsche TR; Pottumarthy S
Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
[TBL] [Abstract][Full Text] [Related]
20. In-vitro studies with ceftazidime.
Giamarellou H; Avlami A; Matsakas V; Kosmidis J; Daikos GK
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():73-7. PubMed ID: 19802972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]